Paclitaxel for treatment of advanced small cell lung cancer (SCLC): a retrospective study of 185 patients
Background: Etoposide-/platinum-based chemotherapy is the standard first-line treatment for extensive- disease small cell lung cancer (SCLC), but responses are short-lived and subsequent options limited. Here, we present our experience with paclitaxel in advanced treatment lines. - Methods: We re...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
[2020]
|
| In: |
Journal of thoracic disease
Year: 2020, Jahrgang: 12, Heft: 3, Pages: 782-793 |
| ISSN: | 2077-6624 |
| DOI: | 10.21037/jtd.2019.12.74 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.21037/jtd.2019.12.74 Verlag, kostenfrei, Volltext: http://jtd.amegroups.com/article/view/35170 
|
| Verfasserangaben: | Damian von Eiff, Farastuk Bozorgmehr, Inn Chung, Denise Bernhardt, Stefan Rieken, Stephan Liersch, Thomas Muley, Sonja Kobinger, Michael Thomas, Petros Christopoulos, Martin Steins |
MARC
| LEADER | 00000caa a22000002c 4500 | ||
|---|---|---|---|
| 001 | 1694876837 | ||
| 003 | DE-627 | ||
| 005 | 20230427070539.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200417s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.21037/jtd.2019.12.74 |2 doi | |
| 035 | |a (DE-627)1694876837 | ||
| 035 | |a (DE-599)KXP1694876837 | ||
| 035 | |a (OCoLC)1151766749 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Eiff, Damian von |d 1993- |e VerfasserIn |0 (DE-588)1143634853 |0 (DE-627)1002916240 |0 (DE-576)495110213 |4 aut | |
| 245 | 1 | 0 | |a Paclitaxel for treatment of advanced small cell lung cancer (SCLC) |b a retrospective study of 185 patients |c Damian von Eiff, Farastuk Bozorgmehr, Inn Chung, Denise Bernhardt, Stefan Rieken, Stephan Liersch, Thomas Muley, Sonja Kobinger, Michael Thomas, Petros Christopoulos, Martin Steins |
| 264 | 1 | |c [2020] | |
| 300 | |a 12 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 17.04.2020 | ||
| 520 | |a Background: Etoposide-/platinum-based chemotherapy is the standard first-line treatment for extensive- disease small cell lung cancer (SCLC), but responses are short-lived and subsequent options limited. Here, we present our experience with paclitaxel in advanced treatment lines. - Methods: We retrospectively studied the clinical course of all paclitaxel-treated SCLC patients between 2005 and 2015 in our institution. Prognostic and predictive factors were analyzed by Kaplan-Meier and Cox regression analyses. - Results: A total of 185 patients [119 men, median age 65 years, median ECOG performance status (PS) 1] were identified. One hundred and sixty-eight patients had extensive disease (ED) at the time of paclitaxel therapy. Paclitaxel was mainly given as third- or fourth-line therapy (93%). The response rate (RR) was 17% and disease control rate (DCR) 28%. Patients reached a median progression-free survival (PFS) of 1.6 (95% CI: 1.4-1.8) months and median overall survival (OS) of 3.3 (95% CI: 2.8-3.9) months. Main toxicities were fatigue (25%) and polyneuropathy (17%). Dose reduction of ≥25% was associated with shorter PFS [1.9 (95% CI: 1.5-2.3) vs . 1.4 (95% CI: 1.3-1.5) months; P=0.004]. Further independent predictive factors for PFS were gender, age, and hepatic/brain metastases (P vs . 62%), as well as a comparable DCR (29% vs . 28%), which was associated with prolonged survival (4.5 vs . 3.2 months for refractory cases, P=0.034). - Conclusions: Paclitaxel has clinically relevant activity in heavily pretreated SCLC. While patients with good PS and no cerebral/hepatic metastases derive the greatest benefit, ECOG PS 2 per se should not be used as a criterion to exclude patients. | ||
| 700 | 1 | |a Bozorgmehr, Farastuk |d 1979- |e VerfasserIn |0 (DE-588)141921811 |0 (DE-627)632526734 |0 (DE-576)326848150 |4 aut | |
| 700 | 1 | |a Chung, Inn |e VerfasserIn |0 (DE-588)1017963711 |0 (DE-627)679809740 |0 (DE-576)354707841 |4 aut | |
| 700 | 1 | |a Bernhardt, Denise |d 1987- |e VerfasserIn |0 (DE-588)1074875338 |0 (DE-627)832630691 |0 (DE-576)443070970 |4 aut | |
| 700 | 1 | |a Rieken, Stefan |d 1979- |e VerfasserIn |0 (DE-588)135553385 |0 (DE-627)567062570 |0 (DE-576)278641725 |4 aut | |
| 700 | 1 | |a Liersch, Stephan |e VerfasserIn |0 (DE-588)1208635514 |0 (DE-627)1694944581 |4 aut | |
| 700 | 1 | |a Muley, Thomas |e VerfasserIn |0 (DE-588)1056885432 |0 (DE-627)794179169 |0 (DE-576)16759284X |4 aut | |
| 700 | 1 | |a Kobinger, Sonja |e VerfasserIn |0 (DE-588)1158693354 |0 (DE-627)1020768347 |0 (DE-576)504307606 |4 aut | |
| 700 | 1 | |a Thomas, Michael |e VerfasserIn |0 (DE-588)1054438781 |0 (DE-627)79152213X |0 (DE-576)41027089X |4 aut | |
| 700 | 1 | |a Christopoulos, Petros |d 1977- |e VerfasserIn |0 (DE-588)138659702 |0 (DE-627)604886756 |0 (DE-576)308488067 |4 aut | |
| 700 | 1 | |a Steins, Martin |d 1971- |e VerfasserIn |0 (DE-588)121323900 |0 (DE-627)705384837 |0 (DE-576)292647379 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of thoracic disease |d Hong Kong : AME Publishing Company, 2009 |g 12(2020), 3, Seite 782-793 |h Online-Ressource |w (DE-627)635603896 |w (DE-600)2573571-8 |w (DE-576)330413570 |x 2077-6624 |7 nnas |a Paclitaxel for treatment of advanced small cell lung cancer (SCLC) a retrospective study of 185 patients |
| 773 | 1 | 8 | |g volume:12 |g year:2020 |g number:3 |g pages:782-793 |g extent:12 |a Paclitaxel for treatment of advanced small cell lung cancer (SCLC) a retrospective study of 185 patients |
| 856 | 4 | 0 | |u https://doi.org/10.21037/jtd.2019.12.74 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u http://jtd.amegroups.com/article/view/35170 |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20200417 | ||
| 993 | |a Article | ||
| 994 | |a 2020 | ||
| 998 | |g 121323900 |a Steins, Martin |m 121323900:Steins, Martin |d 910000 |d 950000 |d 950900 |e 910000PS121323900 |e 950000PS121323900 |e 950900PS121323900 |k 0/910000/ |k 1/910000/950000/ |k 2/910000/950000/950900/ |p 11 |y j | ||
| 998 | |g 138659702 |a Christopoulos, Petros |m 138659702:Christopoulos, Petros |d 50000 |d 910000 |d 950000 |d 950900 |e 50000PC138659702 |e 910000PC138659702 |e 950000PC138659702 |e 950900PC138659702 |k 0/50000/ |k 0/910000/ |k 1/910000/950000/ |k 2/910000/950000/950900/ |p 10 | ||
| 998 | |g 1054438781 |a Thomas, Michael |m 1054438781:Thomas, Michael |d 910000 |d 950000 |d 950900 |d 50000 |e 910000PT1054438781 |e 950000PT1054438781 |e 950900PT1054438781 |e 50000PT1054438781 |k 0/910000/ |k 1/910000/950000/ |k 2/910000/950000/950900/ |k 0/50000/ |p 9 | ||
| 998 | |g 1158693354 |a Kobinger, Sonja |m 1158693354:Kobinger, Sonja |d 910000 |d 950000 |d 950900 |e 910000PK1158693354 |e 950000PK1158693354 |e 950900PK1158693354 |k 0/910000/ |k 1/910000/950000/ |k 2/910000/950000/950900/ |p 8 | ||
| 998 | |g 1056885432 |a Muley, Thomas |m 1056885432:Muley, Thomas |d 910000 |d 950000 |d 950900 |e 910000PM1056885432 |e 950000PM1056885432 |e 950900PM1056885432 |k 0/910000/ |k 1/910000/950000/ |k 2/910000/950000/950900/ |p 7 | ||
| 998 | |g 1208635514 |a Liersch, Stephan |m 1208635514:Liersch, Stephan |d 910000 |d 950000 |d 950900 |e 910000PL1208635514 |e 950000PL1208635514 |e 950900PL1208635514 |k 0/910000/ |k 1/910000/950000/ |k 2/910000/950000/950900/ |p 6 | ||
| 998 | |g 135553385 |a Rieken, Stefan |m 135553385:Rieken, Stefan |d 910000 |d 911400 |e 910000PR135553385 |e 911400PR135553385 |k 0/910000/ |k 1/910000/911400/ |p 5 | ||
| 998 | |g 1074875338 |a Bernhardt, Denise |m 1074875338:Bernhardt, Denise |d 910000 |d 911400 |e 910000PB1074875338 |e 911400PB1074875338 |k 0/910000/ |k 1/910000/911400/ |p 4 | ||
| 998 | |g 1017963711 |a Chung, Inn |m 1017963711:Chung, Inn |d 910000 |d 950000 |d 950900 |e 910000PC1017963711 |e 950000PC1017963711 |e 950900PC1017963711 |k 0/910000/ |k 1/910000/950000/ |k 2/910000/950000/950900/ |p 3 | ||
| 998 | |g 141921811 |a Bozorgmehr, Farastuk |m 141921811:Bozorgmehr, Farastuk |d 910000 |d 950000 |d 950900 |e 910000PB141921811 |e 950000PB141921811 |e 950900PB141921811 |k 0/910000/ |k 1/910000/950000/ |k 2/910000/950000/950900/ |p 2 | ||
| 999 | |a KXP-PPN1694876837 |e 3624951815 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"recId":"1694876837","physDesc":[{"extent":"12 S."}],"relHost":[{"pubHistory":["1.2009 -"],"language":["eng"],"origin":[{"dateIssuedDisp":"2015-","publisher":"AME Publishing Company ; Pioneer Bioscience Publ.","dateIssuedKey":"2015","publisherPlace":"Hong Kong ; Hong Kong"}],"id":{"issn":["2077-6624"],"eki":["635603896"],"zdb":["2573571-8"]},"part":{"text":"12(2020), 3, Seite 782-793","year":"2020","pages":"782-793","issue":"3","volume":"12","extent":"12"},"disp":"Paclitaxel for treatment of advanced small cell lung cancer (SCLC) a retrospective study of 185 patientsJournal of thoracic disease","title":[{"title_sort":"Journal of thoracic disease","title":"Journal of thoracic disease"}],"recId":"635603896","physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 10.11.25"],"titleAlt":[{"title":"JTD"}],"type":{"bibl":"periodical","media":"Online-Ressource"}}],"note":["Gesehen am 17.04.2020"],"language":["eng"],"origin":[{"dateIssuedDisp":"[2020]","dateIssuedKey":"2020"}],"id":{"eki":["1694876837"],"doi":["10.21037/jtd.2019.12.74"]},"person":[{"given":"Damian von","family":"Eiff","role":"aut","display":"Eiff, Damian von"},{"given":"Farastuk","family":"Bozorgmehr","role":"aut","display":"Bozorgmehr, Farastuk"},{"given":"Inn","family":"Chung","role":"aut","display":"Chung, Inn"},{"display":"Bernhardt, Denise","role":"aut","family":"Bernhardt","given":"Denise"},{"given":"Stefan","display":"Rieken, Stefan","role":"aut","family":"Rieken"},{"family":"Liersch","display":"Liersch, Stephan","role":"aut","given":"Stephan"},{"role":"aut","display":"Muley, Thomas","family":"Muley","given":"Thomas"},{"given":"Sonja","display":"Kobinger, Sonja","role":"aut","family":"Kobinger"},{"family":"Thomas","role":"aut","display":"Thomas, Michael","given":"Michael"},{"given":"Petros","family":"Christopoulos","role":"aut","display":"Christopoulos, Petros"},{"given":"Martin","display":"Steins, Martin","role":"aut","family":"Steins"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"title":[{"title_sort":"Paclitaxel for treatment of advanced small cell lung cancer (SCLC)","title":"Paclitaxel for treatment of advanced small cell lung cancer (SCLC)","subtitle":"a retrospective study of 185 patients"}],"name":{"displayForm":["Damian von Eiff, Farastuk Bozorgmehr, Inn Chung, Denise Bernhardt, Stefan Rieken, Stephan Liersch, Thomas Muley, Sonja Kobinger, Michael Thomas, Petros Christopoulos, Martin Steins"]}} | ||
| SRT | |a EIFFDAMIANPACLITAXEL2020 | ||